Catalyst Pharmaceuticals, Inc. financial data

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Catalyst Pharmaceutical Partners, Inc. (to 5/12/2015), CATALYST PHARMACEUTICAL PARTNERS, INC. (to 5/12/2015)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 463 % +9.25%
Quick Ratio 20.8 % +26.8%
Debt-to-equity 17 % -18.3%
Return On Equity 25.7 % +40.9%
Return On Assets 22 % +45.5%
Operating Margin 37.8 % +73.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119M shares +11.9%
Common Stock, Shares, Outstanding 119M shares +11.9%
Entity Public Float 1.34B USD +102%
Common Stock, Value, Issued 119K USD +11.2%
Weighted Average Number of Shares Outstanding, Basic 119M shares +11.6%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +17.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 460M USD +32.2%
Research and Development Expense 10.8M USD -88.6%
Operating Income (Loss) 174M USD +129%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 189M USD +134%
Income Tax Expense (Benefit) 46M USD +145%
Net Income (Loss) Attributable to Parent 143M USD +130%
Earnings Per Share, Basic 1.24 USD/shares +110%
Earnings Per Share, Diluted 1.2 USD/shares +126%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 442M USD +266%
Accounts Receivable, after Allowance for Credit Loss, Current 58.3M USD +21.3%
Inventory, Net 20M USD +122%
Assets, Current 539M USD +181%
Deferred Income Tax Assets, Net 48.5M USD +29.5%
Property, Plant and Equipment, Net 1.38M USD +16.4%
Operating Lease, Right-of-Use Asset 2.3M USD -10.6%
Assets 772M USD +86.8%
Accounts Payable, Current 11.6M USD +151%
Employee-related Liabilities, Current 8.01M USD +52%
Accrued Liabilities, Current 93.8M USD +76.3%
Liabilities, Current 105M USD +82.3%
Operating Lease, Liability, Noncurrent 2.89M USD -12%
Other Liabilities, Noncurrent 2.79M USD -22.1%
Liabilities 111M USD +71.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) 229M USD +165%
Stockholders' Equity Attributable to Parent 661M USD +89.6%
Liabilities and Equity 772M USD +86.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.9M USD +164%
Net Cash Provided by (Used in) Financing Activities 141M USD +94564%
Net Cash Provided by (Used in) Investing Activities -199K USD +99.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 119M shares +11.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 442M USD +266%
Interest Paid, Excluding Capitalized Interest, Operating Activities 65K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 38.3M USD +91.4%
Operating Lease, Liability 3.28M USD -9.91%
Depreciation 86K USD +24.6%
Payments to Acquire Property, Plant, and Equipment 199K USD +169%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 143M USD +130%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD -11.9%
Operating Lease, Liability, Current 393K USD +8.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 537K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 536K USD -22.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 570K USD +3.07%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 587K USD +2.98%
Operating Lease, Payments 129K USD +3.2%
Additional Paid in Capital 432M USD +64.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.34M USD +43.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%